A phase I trial of isolated hepatic perfusion (IHP) using 5-FU and oxaliplatin in patients with unresectable isolated liver metastases (ILM) from colorectal cancer (CRC). A phase II study to evaluate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback